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Abstract
The Vi capsular polysaccharide is a virulence-associated factor expressed by Salmonella enterica serotype Typhi but absent
from virtually all other Salmonella serotypes. In order to study this determinant in vivo, we characterised a Vi-positive S.
Typhimurium (C5.507 Vi
+), harbouring the Salmonella pathogenicity island (SPI)-7, which encodes the Vi locus. S.
Typhimurium C5.507 Vi
+ colonised and persisted in mice at similar levels compared to the parent strain, S. Typhimurium C5.
However, the innate immune response to infection with C5.507 Vi
+ and SGB1, an isogenic derivative not expressing Vi,
differed markedly. Infection with C5.507 Vi
+ resulted in a significant reduction in cellular trafficking of innate immune cells,
including PMN and NK cells, compared to SGB1 Vi
2 infected animals. C5.507 Vi
+ infection stimulated reduced numbers of
TNF-a, MIP-2 and perforin producing cells compared to SGB1 Vi
2. The modulating effect associated with Vi was not
observed in MyD88
2/2 and was reduced in TLR4
2/2 mice. The presence of the Vi capsule also correlated with induction of
the anti-inflammatory cytokine IL-10 in vivo, a factor that impacted on chemotaxis and the activation of immune cells in
vitro.
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Introduction
The genus Salmonella comprises serotypes with a range of host
adaptation, and spectrum of disease syndromes ranging from self-
limiting gastroenteritis, bacteraemia and typhoid fever. The
outcome of the host-pathogen interaction is dependent on the
combination of the host species, host immune status and the
repertoire of virulence factors encoded in the genome of the
Salmonella pathogen. Typhoid fever is a systemic disease caused by
Salmonella enterica serovar Typhi (S. Typhi), a serotype that is highly
host-adapted to the human host. Typhoid disease is characterised
by a slow onset, protracted fever and a relatively high frequency of
chronic carriage [1]. Although fever is ultimately an important
feature of typhoid, progression of the disease is relatively slow and
septic shock is uncommon. Although pyrogenic cytokines are
elevated in typhoid patients [2,3], they are nonetheless low relative
to patients with sepsis [4,5].
Typhoid fever has been extensively studied using the surrogate
pathogen S. Typhimurium infections in genetically susceptible
mouse. This model has been used successfully to study many
aspects of typhoid fever where S. Typhi and S. Typhimurium
employ common virulence mechanisms. A significant antigenic
difference between S. Typhi and S. Typhimurium is the expression
of the Vi polysaccharide capsule by Typhi. The Vi locus is
encoded on the 134 kb Salmonella pathogenicity island (SPI) 7 that
is not present in non-typhoid Salmonella serotypes such as S.
Typhimurium. The Vi locus, known as viaB, encodes genes
involved in Vi regulation (tviA), biosynthesis (tviBCDE) and export
(vexABCDE) [6]. S. Typhi that express Vi are more virulent than
equivalent Vi-negative S. Typhi in volunteers and Vi is expressed
by virtually all clinical isolates of S. Typhi [7]. TNF-a production
by J774 macrophage-like cells and transcription of GRO-a and IL-
17 genes in the intestine of streptomycin pre-treated mice, bovine
ileal loops and human colonic explants was decreased as a result of
expression of the Vi polysaccharide by S. Typhimurium [8,9].
Furthermore, TNF-a and i-NOS expression in the liver of mice
was similarly decreased in response to expression of Vi [10].
Here we characterise the expression of the Vi polysaccharide
capsule by a S. Typhimurium/S. Typhi genomic chimera in vitro,
and the early innate immune response to infection in the murine
typhoid model. We test the hypothesis that S. Typhimurium
containing the entire SPI-7 region and expressing the Vi
polysaccharide capsule modulates the murine immune response
during the systemic phase of infection resulting in altered immune
cell populations in the spleen and mesenteric lymph nodes and the
intracellular cytokine response. Our results further define the
genetic basis of S. Typhi pathogenesis and host adaptation, and
propose an improved murine typhoid model for developing
PLoS Pathogens | www.plospathogens.org 1 July 2011 | Volume 7 | Issue 7 | e1002131intervention strategies to combat typhoid fever, including Vi
polysaccharide based vaccines.
Results
S. Typhimurium C5507 Vi
+ harbours SPI-7 of S. Typhi and
expresses Vi capsular polysaccharide
S. Typhimurium C5.507 Vi
+ was constructed by hfr conjugation
between S. Typhi Ty2 and S. Typhimurium C5 during which a
previously undefined region of the chromosome of S. Typhi Ty2
was transferred to S. Typhimurium (Personal Communication,
M.Y. Poppoff). An exconjugant designated C5.507 Vi
+, was
agglutinated with anti-Vi antiserum and antiserum raised to the
somatic antigens O4, O5 and O12. This suggested that genes
required for Vi biosynthesis are present in C5.507 Vi
+, but that the
S. Typhi-derived genome did not include genes encoding the
determinants of S. Typhi O antigens (O9, O12). To define the
extent of S. Typhi genome we used an Illumina Genome Analyzer
(Illumina, GA) to determine 36 bp single end nucleotide reads
from 300 bp fragments of C5.507 Vi
+ genome. We then
determined S. Typhi and S. Typhimurium-specific single nucle-
otide polymorphisms (SNPs) by mapping reads to the complete
genome sequences of S. Typhimurium LT2 and S. Typhi CT18
(Figure 1). As these were single end reads we were unable to
assemble the genome, but nonetheless the S. Typhimurium and S.
Typhi SNP density defined the origin of the chimeric genome
sequence (Figure 1). Most of the uniquely mapped reads of C5.507
Vi
+ contained a low SNP frequency when mapped to the LT2
genome and a relatively high SNP frequency when mapped to S.
Typhi CT18 consistent with a relatively small region of the S.
Typhi genome recombining into a predominantly S. Typhimur-
ium C5 background. Two regions of elevated SNP frequency were
identified, when Illumina reads were mapped to the LT2 genome.
The first mapped to the Fels-2 prophage element of LT2, showing
that a related but distinct phage is present in the C5.507 Vi
+
genome reflecting the distinct phage repertoire of LT2 and C5. A
second region of high SNP density mapped to the SPI-7 region of
S. Typhi. This spanned the region from the 59 end of the gltP gene
to the intergenic region of STY4805 and STY4806, a total of
298 kb of the S. Typhi genome including the entire SPI-7 genomic
island. This indicated that nearly 7% of the S. Typhi genome was
present in the C5.507 Vi
+.
The viaB locus harbours genes necessary for the biosynthesis,
secretion and anchoring of the Vi polysaccharide antigen on the
bacterial cell surface [6]. Surface structures resembling a capsule
were visualised by transmission electron microscopy (TEM) of the
control S. Typhi BRD948 and S. Typhimurium C5.507 Vi
+
cultured in rich medium containing 0.09 M NaCl. This structure
was absent from S. Typhimurium C5.507 Vi
+ in which the tviB
gene, that encodes an essential component of the biosynthesis
pathway, had been deleted (SGB1) (Figures 2A–C). Furthermore,
SGB1 did not agglutinate with anti-Vi antiserum. The presence of
Vi on the surface of S. Typhi and S. Typhimurium was visualised
and semi-quantified by immunogold labelling with anti-Vi coated
gold beads (Figures 2D–E and Figure 3). S. Typhimurium SGB1
cells were not associated with gold beads, while in contrast C5.507
Vi
+ were significantly associated with anti-Vi
+ coated gold beads.
In S. Typhi the viaB locus is positively regulated by the two-
component regulator OmpR/EnvZ in response to osmotic
tension. In elevated NaCl concentration the viaB locus is reported
to be down-regulated. [11,12,13]. We quantified immuno-gold
labelling with anti-Vi antibody following culture at 0.09 M and
0.3 M NaCl. Culture of S. Typhimurium C5.507 Vi
+ in media
containing 0.09 M NaCl resulted in ,2-fold increase in labelling
than that observed following culture in 0.3 M NaCl. Furthermore,
a derivative in which the ompR gene was inactivated by deletion
was not labelled, even when cultured in low osmolarity medium
(LB+0.09 M NaCl). The quantification of labelling with anti-Vi
+
coated gold beads correlated with the lack of agglutination with
anti-Vi serum. Together these data indicate that the entire SPI-7
region of S. Typhi is integrated into the S. Typhimurium genome
in C5.507 Vi
+ and the pattern of expression of Vi antigen is similar
to that in S. Typhi.
Expression of Vi polysaccharide by S. Typhimurium does
not impact colonisation of C57BL/6 mice following oral
inoculation
S. Typhi are host-adapted to higher primates and attenuated in
mice following inoculation by the oral or parenteral routes.
Consequently, we determined if S. Typhimurium C5.507 Vi
+
could colonise the genetically susceptible C57BL/6 mouse. Mice
were inoculated by oral gavage with approximately 1610
8 CFU S.
Typhimurium C5, C5.507 Vi
+ or SGB1 (DtviB). No significant
difference in the colonisation of MLN, ceacum, ileum, spleen or
liver was observed for these derivatives five days post inoculation
(Figure 4A). To further determine the effects of the Vi capsule on
chronic colonization as well as shedding within the faeces, we
inoculated 129/sv mice by oral gavage with a mixture containing
approximately 1610
9 CFU C5.507 Vi
+ or SGB1. C5.507 Vi
+ and
SGB1 Vi
2 were shed in the stool at similar levels on day 1, 4, 7
and 10 post inoculation (Figure 4B).
Infection with S. Typhimurium C5.507 Vi
+ results in
altered innate immune cell population in spleen
compared to a Vi-negative derivative
To determine the impact of Vi expression on early innate
immune responses to S. Typhimurium infection, spleens and MLN
Author Summary
Pathogens of the genus Salmonella are closely related yet
cause distinct diseases and have different host-range.
Salmonella Typhi causes a systemic disease called typhoid
fever specifically in humans, and is commonly modelled
using a surrogate host-pathogen combination, namely
Salmonella Typhimurium infection in mice. However, key
virulence mechanisms of S. Typhi depend on the Vi
polysaccharide capsule that is not expressed by S.
Typhimurium. In order to study the function of the Vi
capsule we characterised a S. Typhimurium/S. Typhi
chimera that expresses the Vi polysaccharide in a
regulated manner similar to that previously described in
S. Typhi. The impact of Vi expression on immune cell
populations in the spleen and mesenteric lymph nodes,
and the pattern of intracellular cytokine response was
determined 24 hours after i.v or i.g inoculation. Infection of
mice with S. Typhimurium expressing Vi polysaccharide
resulted in a blunted response in recruitment of NK and
PMN cells. This was reflected in a blunted proinflammatory
cytokine response, but a striking increase in the anti-
inflammatory cytokine IL-10. IL-10 was expressed in
macrophage, dendritic cells and NK cells in the mouse
spleen, specifically in response to infection with S.
Typhimurium expressing Vi polysaccharide. Indeed, neu-
tralisation of this IL-10 production lead to increased
migration and activation of splenocytes in vitro. This
model can be used to develop Vi based vaccines as well as
to study the impact of Vi expression on pathogenesis.
Salmonella Chimera Expressing Vi Polysacharide
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C5.507 Vi
+ or SGB1 tviB (Vi
2) were examined by flow cytometry
24 hours post-inoculation. This time point was chosen since we
were interested in determining the early innate immune response
and because Vi is expressed on the surface of C5.507 Vi
+ during
this period but is down regulated by four days post inoculation
[14]. Interestingly, mice inoculated with the SGB1 Vi
2, had a
small but significant increase in the levels of bacterial spleen
colonisation (p=0.025, unpaired, two tail, Mann Whitney) at 24 h
compared to mice infected with C5.507 Vi
+ (Figure 5).
Examination of the spleen population of CD11c
+ (dendritic
cells, DC), F4/80
+ (macrophage, MW), DX5
+/CD3
2 (natural
killer, NK) cells and Ly6G
+ (polymorphonuclear, PMN) in C5.507
Vi
+ or SGB1 (Vi
2) infected mice revealed differences in immune
cell populations during early infection that correlated with the
presence of a functional Vi locus (Figure 6A and Table 1).
Infection with C5.507 Vi
+ resulted in moderate but significant
increases (p,0.05) in both percentage and total cell numbers of
PMN in spleens at 24 h when compared to naı ¨ve animals,
although other immune cells monitored were largely unchanged.
In contrast, spleens from mice at 24 h after inoculation with SGB1
Vi
2 had dramatically increased (p,0.001) percentage of PMN
and NK cells, a significant increase (p,0.001) in the total number
of DC and MW, although as a percentage they were not different
form the population of these cells in spleen from naı ¨ve animals.
We also observed an increase in the percentage of NK and PMN
cells in mice infected with SGB1 Vi
2 compared to C5.507 Vi
+ and
an increase in the total number of both DC and MW populations.
During natural infection following oral ingestion S. Typhimur-
ium invades the enterocytes and M cells of the terminal ileum and
then enters the lymph system that drains via the mesenteric lymph
nodes (MLN). We therefore determined the impact of Vi
expression on the innate immune cell populations of the MLN
24 hours after oral infection (Figure 6B and Table 1). Similar but
not identical patterns of splenocyte immune cell populations were
observed. For example, mice inoculated with SGB1 Vi
2 had a
dramatically increased (p,0.001) percentages of PMN and NK
cells in the MLN compared with MLN from C5.507 Vi
+ infected
Figure 1. SNP density of S. Typhimurium C5.507 Vi
+ mapped to S. Typhimurium LT2 and S. Typhi CT18. The boundaries of genomic
sequence of S. Typhimurium and S. Typhi origin were determined by calculating the SNP density identified by mapping Illumina GA short reads from
S. Typhimurium C5507 to the S. Typhimurium LT2 and S. Typhi Ty2 reference genome sequence. Artemis comparison tool (ACT) view of the left (A)
and right (B) boundaries are shown with the position of SNPs in S. Typhimurium C5507 sequence reads mapped to either the S. Typhimurium LT2 or
S. Typhi Ty2 genome. The SNP density (C) determined by mapping Illumina GA short reads from S. Typhimurium C5507 to the S. Typhimurium LT2
reference genome. The peak at 2.8 megabases is due to related but distinct prophage elements in S. Typhimurium C5507 genome relative to LT2 and
the peak at 4.5 to 4.8 Mb is the S. Typhi genome sequence flanking SPI-7. Sequence reads from SPI-7 were not mapped to LT2 since this region is
absent from S. Typhimurium. The deduced mosaic structure of the S. Typhimurium C5507 genome (D) with genomic sequence of S. Typhimurium C5
origin (black line) and S. Typhi Ty2 genome (green line) and SPI-7 (blue line) indicated.
doi:10.1371/journal.ppat.1002131.g001
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i.v. inoculated mice in which we observed a significant increase in
the percentage of PMN with C5.507 Vi
+, PMN in MLN following
infection with C5.507 was not significantly different from naı ¨ve
animals.
Vi expression modulates cytokine and chemokine
responses
The intracellular cytokine response to Vi
+ and Vi
2 S. Typhimur-
ium were determined following ex vivo stimulation of splenocyte and
MLN cells with phorbol 12-myristate 13-acetate (PMA). Flow
cytometric analysis of intracellular cytokine expression in both
splenocytes (after i.v. infection) and MLN cells (after oral infection)
from Salmonella-infected mice were determined (Figure 7 and
Table 2). Infection with SGB1 Vi
2 was associated with a significant
increase (p,0.05) in the percentage and total cell number of MIP-2,
TNF-a, IFN-c and perforin producing splenocytes cells when
compared to similarly stimulated naı ¨ve cells. In the case of MIP-2,
IFN-c and perforin producing cells from mice infected with C5.507
Vi
+ the levels were not significantly different than those from naı ¨ve
animals.Additionally, although,we did observe a significant increase
in the proportion of TNF-a positive cells compared to naı ¨ve animals
thiswassignificantlylower(p,0.05) than observedincellsfrom mice
infected with SGB1 Vi
2. There was no observed difference in IL-6
expression by splenocytes from naı ¨ve mice or mice infected with
C5507 Vi
+ or SGB1 Vi
2.
Since the natural route of infection for Salmonella is via the oral
route we also determined the impact of infection with S.
Typhimurium C5507 Vi
+ and SGB1 Vi
2 on intracellular
production of MIP-2, TNF-a, IFN-c and perforin by immune
cells of the MLNs 24 h post inoculation. Similar observations were
made to those found in splenocytes following i.v. inoculation but
differences in IFN-c
+ cell populations and IL-6 producing cells
were observed. IFN-c
+ splenocytes were elevated, but not IFN-c
+
MLN cells, and significantly greater percentages and numbers of
IL-6 producing MLN cells, but no significant differences in the IL-
6 splenocyte population in SGB1 Vi
2 infected mice when
compared to naı ¨ve animals. With respect to SGB1 Vi
2 infected
mice, we also detected a significant increase (p,0.05) in the
percentage of TNF-a producing splenocytes and MLN cells.
We also determined the cellular source of these cytokines within
the lymphoid tissues after infection (Table 3). Splenocytes isolated
from SGB1 Vi
2 infected mice were found to have significantly
more MIP-2
+ and IFN-c
+ (p,0.001) producing cells compared to
both naive and C5.507 Vi
+ infected mice. TNF-a was mainly
expressed by macrophage and NK cells and to a lesser extent
PMN. IL-6 expression was only significantly different in NK cells
in SGB1 Vi
2 infected compared toC5.507 Vi
+ infected or
uninfected mice. Also the numbers of macrophage detectably
producing IL-6 from Vi
+ infected mice was significantly (p,0.05)
lower than both naı ¨ve and Vi
2 infected mice. The numbers of
perforin
+ NK cells was significant higher (p,0.001) in those mice
Figure 2. Transmission electron microscopy (TEM) images of S. Typhi and S. Typhimurium showing expression of Vi polysaccharide.
S. Typhi (A), S. Typhimurium C5507 (B), S. Typhimurium SGB1 (C5507 DtviB::kan
r) (C) visualised using TEM. S. Typhi (D), S. Typhimurium C5507 (E), S.
Typhimurium SGB1 (C5507 DtviB::kan
r) (F) visualised using TEM in conjunction with immunogold labelling using anti-Vi antibody.
doi:10.1371/journal.ppat.1002131.g002
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2 compared to naı ¨ve and C5.507 Vi
+
infected mice. A similar cytokine profile was also observed within
the MLN from orally infected mice. Notably, the cellular sources
of the significant increase in IL-6
+ MLN cells from SGB1 Vi
2
infected mice included DC, MW and NK cells (data not shown).
Strikingly, infection with C5507 Vi
+ was also associated with a
significant increase in the percentage and total number of cells
producing the anti-inflammatory cytokine IL-10 when compared
to both stimulated naı ¨ve and SGB1 Vi
2 infected cells. Indeed, no
increase in the number of cells producing IL-10 above that in
naı ¨ve resulted from infection with SGB1 Vi
2. We observed that
re-stimulated MW, DC and NK cells, but not PMN, from C5.507
Vi
+ infected mice expressed significantly more (p,0.01) IL-10
when compared to similarly stimulated naı ¨ve and Vi
2 infected
splenocytes (Figure 7C).
Vi expression modulates in vivo innate immune
responses in a TLR-dependent manner
To determine if the observed differences in the innate immune
response in mice infected with Vi
+ S. Typhimurium were due to
detection of PAMPs by TLRs, we infected both MyD88
2/2 and
TLR4
2/2 mice with SGB1 Vi
2 or C5507Vi
+. Both bacterial
colonisation and splenocyte PMN and NK cell populations were
examined 24 h post-infection in wild type and KO mice (Figure 8
and Table 4).
As observed previously, spleens from wild type mice infected
with C5.507 Vi
+ had significantly increased percentage and
number of PMN compared to naı ¨ve mice (p,0.01). In contrast, in
both TLR4
2/2 and MyD88
2/2 mice infected with C5.507 Vi
+
the numbers of PMN was not significantly different (p.0.05) in
percentage or total cell number compared with naı ¨ve mice.
Figure 3. Enumeration of anti-Vi antibody immuno-gold labelling of S. Typhi and S. Typhimurium. The number (filled circle) and the
mean (horizontal bar) of anti-Vi antibody coated gold particles associated with S. Typhi BRD948, and S. Typhimurium C5507 either with no additional
mutations or in which the tviB or ompR gene were deleted. Bacteria were cultured in medium containing NaCl of either 0.09 M (low osmolarity) or
0.3 M (high osmolarity).
doi:10.1371/journal.ppat.1002131.g003
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DtviB::kan
r). (A) Groups of ten C57BL/6 genetically susceptible mice were inoculated orally with 1610
8 cfu of S. Typhimurium C5 (closed circles), S.
Typhimurium C5507 (open circles), or S. Typhimurium SGB1 (C5507 DtviB::kan
r) (closed squares). Horizontal bar indicates the geometric mean. Mice
were culled on day 5 post-inoculation and the cfu in mesenteric lymph nodes, cecum, ileum, spleen and liver homogenates determined. (B) A group
of five 129/sv genetically resistant mice were inoculated orally with an equal mixture of 1610
9 CFU S. Typhimurium C5507 Vi
+, and S. Typhimurium
SGB1 Vi
2 (C5507 DtviB::kan
r). The mean log10 ratio of these two strains in fresh fecal pellets on days 1, 4, 7 and 10 post inoculation are plotted (top),
the CFU per 100 mg of S. Typhimurium C5507 Vi
+ (open circles) and S. Typhimurium SGB1 Vi
2 (filled circles) are plotted (below).
doi:10.1371/journal.ppat.1002131.g004
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2/2 and MyD88
2/2 infected mice the
PMN and NK cell response to C5.507 Vi
+ infection was
indistinguishable from naı ¨ve mice. In contrast, although the
response to SGB1 Vi
2 infection in TLR4
2/2 and MyD88
2/2 was
reduced compared to that in WT mice, there was still a significant
response compared to naı ¨ve mice.
Infection of wild type mice with SGB1 Vi
2 as before resulted in
a significant increase (p,0.001) in the PMN population compared
to both naı ¨ve and C5.507 Vi
+ infected mice. Furthermore, unlike
infections with C5.507 Vi
+, both TLR4
2/2 and MyD88
2/2 mice
infected with SGB1 Vi
2 also had significantly more (p,0.05)
PMN within their spleen compared with naı ¨ve mice. Indeed,
when wild type TLR4
2/2 and MyD88
2/2 mice infected with
SGB1 Vi
2 were compared, both TLR4
2/2 and MyD88
2/2 mice
had significantly less (p,0.001) PMN than wild type infected mice.
Furthermore MyD88
2/2 mice had a significant reduction (p,
0.05) compared to TLR4
2/2 SGB1 Vi
2 infected mice. Impor-
tantly, there were also significantly fewer (p,0.01) PMN in
C5.507 Vi
+ infected TLR4
2/2 mice compared to SGB1 Vi
2
infected mice, but not within the MyD88
2/2 groups.
The splenic NK cell population showed very similar responses
to Vi
+ and Vi
2 S. Typhimurium PMN population in wild type and
TLR4
2/2 and MyD88
2/2 mice (Figure 8B). Specifically, only
Vi
2 infected wild type and TLR4
2/2 infected mice had signi-
ficantly greater percentages and numbers of NK cells compared to
naı ¨ve and C5.507 Vi
+ infected mice. Additionally, both TLR4
2/2
and MyD88
2/2 SGB1 Vi
2 infected mice had significantly lower
levels of NK cells when compared to similarly infected wild type
mice. MyD88
2/2 infected mice also had significantly less NK cells
when compared to TLR4
2/2 SGB1 Vi
2 infected mice. We again
observed that C5.507 Vi
+ infected TLR4
2/2 mice had signifi-
cantly less (p,0.01) NK cells than similar SGB1 Vi
2 infected
mice.
Vi associated IL-10 expression regulates activation and
chemotaxis of splenocytes in vitro
Splenocytes purified from naı ¨ve C57BL/6 mice were cultured
with C5.507 Vi
+ or SGB1 Vi
2 bacteria for 24 h and the
supernatant assayed for the presence of IL-10. The culture
supernatant from cells stimulated with C5.507 Vi
+ contained
higher (p,0.001) IL-10 levels than SGB1 Vi
2 stimulated
splenocytes (Figure 9A). To address directly if enhanced expression
of IL-10 associated with C5.507 Vi
+ infection was at least in part
responsible for the observed immune suppression in infected mice,
splenocytes from naı ¨ve mice were stimulated with Vi
+ or Vi
2 S.
Typhimurium in the presence of anti-IL-10 or isotype control
antibody. Decreased chemotaxis (p,0.01) was observed in SGB1
Vi
2 stimulated isotype treated cultures compared to both isotype
control antibody and anti-IL-10 SGB1 Vi
2 stimulated splenocytes.
Notably, when C5.507 Vi
+ stimulated cultures were grown in the
presence of anti-IL-10 we no longer observed a significant
reduction (p.0.05) in the movement of cells (Figure 9B). C5.507
Vi
+ co-culture with isotype antibody significantly reduced
(p,0.01) both the percentage and mean fluorescent intensity
(MFI), expression levels, of the early activation marker CD69 on
both PMN and NK cells. Again, presence of anti-IL-10 in C5.507
Vi
+ stimulated cultures led to an increase in CD69 expression that
was not significantly different (p.0.05) from SGB1 Vi
2 stimulated
splenocytes (Figure 9C). The addition of anti-IL-10 did not appear
to have any significant effect on migration, although we did
observe a significantly greater percentage of CD69
+ PMN in anti-
IL-10 SGB1 Vi
2 treated cultures compared to isotype controls
(Figure 9B and C). Further, addition of rIL-10 to naı ¨ve splenocytes
gave a similar chemotaxis and immune activation profile (p.0.05)
to that observed in C5.507 Vi
+ stimulated splenocytes containing
control antibody (Figure 9B and C).
Discussion
In this study we addressed the hypothesis that early innate
immune responses to Salmonella can be modulated at systemic sites
by the expression of Vi. We exploit a S. Typhimurium/S. Typhi
chimera (C5.507) harbouring ,300 kb of the S. Typhi genome
including the entire SPI-7 island containing the viaB locus. In our
assays the colonisation level of mice following oral inoculation with
this chimera strain was indistinguishable from the parent strain
lacking the S. Typhi genomic region. However, we cannot
discount small differences in colonisation that may be detectable
in more sensitive experiments. Importantly the viaB locus in this
Figure 5. Colonisation of C57BL/6 mouse spleen by S. Typhimurium C5507, and S. Typhimurium SGB1 (C5507 DtviB::kan
r). Groups of
fifteen C57BL/6 mice were inoculated orally with 1610
5 cfu of S. Typhimurium C5507 (closed circles) or S. Typhimurium SGB1 (C5507 DtviB::kan
r)
(open circles). Mice were culled on 24 hours post-inoculation and the cfu in spleen homogenates determined.
doi:10.1371/journal.ppat.1002131.g005
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context. Consequently, the Vi polysaccharide capsule is expressed
on the surface of C5.507 Vi
+ at similar levels to that in S. Typhi
and expression is controlled by osmotic stress in an OmpR
dependent manner as in S. Typhi [11]. The pathogen chimera
approach could be used to study other S. Typhi specific
determinants or to overcome technical constraints associated with
other host-adapted pathogens.
An immune-modulator role for Vi has been proposed previously
based on observations of the effect of the expression of this
polysaccharide on cytokine responses in T84, THP-1 and
HEK293 cells in tissue culture [15], bone-marrow derived
macrophage [10], and in an in vivo colitis models [9]. In these
studies determination of relative transcription of IL-6, TNF-a,o r
IL-17 genes was generally used as a measure of the immune
response to infection. Here we use an alternative approach to
directly measure both the population of immune cells (macro-
phage, dendritic cells, NK cells and polymorphonuclear cells),
present in the spleen of mice infected with S. Typhimurium
C5.507 Vi
+, and directly determine the intracellular level of a
series of key inflammatory or anti-inflammatory cytokines; MIP-2,
TNF-a, IFN-c, IL-6 and IL-10. When we compared the
splenocyte population 24 h after infection we observed signifi-
cantly fewer PMN in mice inoculated with C5.507 Vi
+ compared
to SGB1 Vi
2. This could be explained by the observation that a
greater number of TNF-a and MIP-2 producing MW, NK cells
and DC were found in those mice infected with the Vi
2 compared
to the Vi
+ S. Typhimurium. Through neutrophil recruitment and
activation, TNF-a and MIP-2 are known to be important
mediators of intestinal inflammation and associated pathology,
and the difference in the induction of these mediators by S. Typhi
and S. Typhimurium may explains some of the differences in
disease outcome associated with these pathogens [9]. We also
report that Vi expression is associated with decreased TNF-a and
MIP-2 expression in the spleen of infected mice following
inoculation by the intravenous route. Vi mediated decrease in
IL-6 production by bone marrow derived macrophages in vitro
has been described previously [10]. However, we only observed
reduced IL-6 expression in cells (MW, DC and NK cells) of the
mesenteric lymph node following oral inoculation but no
detectable difference in intracellular IL-6 levels in mice infected
via the intravenous route regardless of Vi expression. Notably, our
data shows that reductions in neutrophil chemo attractants directly
impacts on their trafficking in vivo. NK cells were also influenced by
the expression of Vi following either intravenous or oral infection
with C5.507 Vi
+ as NK cell populations were not significantly
different from those in naı ¨ve mice. In contrast, mice infected with
SGB1 Vi
2 showed a marked increase in the NK cell population.
We also observed an increase in the proportion of perforin positive
NK cells. Perforin is stored in NK and CD8
+ T cells as granules
and is key to their ability to destroy infected host cells. The
reduction in NK cell influx and associated decrease in perforin in
response to C5.507 Vi
+ infection may also explain in part how
expression of this polysaccharide contributes to the ability of the S.
Typhi to disseminate to systemic sites, colonise and replicate.
The effect of Vi expression by S. Typhimurium on DC and MW
populations was not as great as that observed for PMN and NK
cell populations. Nonetheless, we did observe significantly lower
numbers of these innate cells in mice infected with Vi
+ compared
to Vi
2 S. Typhimurium. The apparent impact of Vi expression on
the infux of DC and MW may also be attributed to MIP-2 since
this chemokine can also modulate the trafficking of DC [16]. As
well as being a chemo attractant in its own right, TNF-a induces
the synthesis of a number of chemokines, including IP-10,
RANTES, KC, in a cell-type and tissue-specific manner [17].
Impairment of this response may also account for the reduction in
splenic MW and NK cells observed in C5.507 Vi
+ infected mice.
Together, these data support a role for Vi in modulating the
recruitment of immune cells to sites beyond the intestinal mucosa,
including the mesenteric lymph nodes and spleen.
The mechanism by which Vi modulates innate responses is
currently not known, although it has been postulated that Vi may
mask LPS therefore preventing its detection by TLR4 [10]. We
report that spleen from TLR4
2/2 and MyD88
2/2 mice infected
with SGB1 Vi
2 have reduced immune cell splenocyte populations
compared to wild type control mice. However, there were
significantly greater immune cell populations in TLR4
2/2 and
MyD88
2/2 mice than in naı ¨ve mice suggesting that proinflam-
matory signals other than those dependent on these were in
operation. These data suggest Vi may play a role as a physical
barrier separating Salmonella PAMPs from TLR4 activation.
However, data from MyD88
2/2 mice suggests that while TLR4
signalling plays some role in the immuno-modulatory aspect of Vi,
other pathways may also be involved.
Much of what is known of the immune-modulator effects of Vi
is from observations of induction of pro-inflammatory cytokines
and chemokines. We additionally examined the production of an
anti-inflammatory cytokine, IL-10, and report a significant
Figure 6. Expression of the Vi capsule induces differential innate immune responses shortly after infection. Cells were isolated from
the spleens after i.v. infection (A) or MLN after oral infection (B) of C57BL/6 mice 24 h after infection with C5507 (Vi
+) or SGB1 (Vi
2) S. Typhimurium
and stained with flurochrome-labelled mAb and analysed by flow cytometry in which 20,000–200,000 events were recorded. Columns represent the
percentage 6 SEM. Significant differences in values of * p,0.05; **, p,0.01; ***, p,0.001, as determined by one-way ANOVA followed by
Bonferroni’s multiple comparison test.
doi:10.1371/journal.ppat.1002131.g006
Table 1. Innate cell numbers after infection with Vi
+ or Vi
2 S.
Typhimurium.
tissue cell type naı ¨ve Vi+ Vi
2
spleen F4/80
+ MW 393.7643.6 587.1665.2 878.5689.1
***{
CD11c
+ DC 138.4615.3 176.8619.1 314.8621.2
***{{{
DX5
+/CD3
2 NK cells 151.4618.6 238.2640.1 891.7682.3
***{{{
Ly6G
+ PMN 223.4629.2 545.7675.7
* 12996115.5
***{{{
MLN F4/80
+ MW 9.661.3 13.161.4 22.262.8
***{{
CD11c
+ DC 6.160.6 9.361.7 15.262.1
***{
DX5
+/CD3
2 NK cells 5.260.7 14.363.0 41.563.4
***{{{
Ly6G
+ PMN 8.761.0 16.862.3 40.268.9
***{{{
Total cell number for spleen (i.v. infection) or MLN (oral infection) after 24 h
(1610
4) 6 SEM.
*indicates significant values of p,0.05;
**, p,0.01;
***, p,0.001, as determined by one-way ANOVA followed by Bonferroni’s
multiple comparison test when compared to naı ¨ve mice.
{indicates significant values of p,0.05;
{{,p ,0.01;
{{{,p ,0.001, as determined by one-way ANOVA followed by Bonferroni’s
multiple comparison test when Vi
+ are compared to Vi
2 infected mice.
doi:10.1371/journal.ppat.1002131.t001
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with Vi
+ compared to Vi
2 S. Typhimurium. In part, IL-10 acts on
macrophage and myeloid dendritic cells to inhibit the develop-
ment of a TH-1 response (reviewed in [18]). IL-10 is produced by
many different cell types of the innate and adaptive immune
systems, and the temporal and spatial expression is likely
important to moderating immune response [19]. Importantly,
IL-10 is induced in macrophage and myeloid dendritic cells by a
variety of pathogen derived products, including LPS following
detection by TLR-4 [20]. We did not observe induction of IL-10
in splenocytes from mice infected with SGB1 Vi
2 relative to naı ¨ve
mice at the time point studied, but induction was specifically
observed in mice infected with C5.507 expressing Vi. Indeed,
when we determined the innate populations producing IL-10 we
observed that MW, DC and NK cells were the cell types
responsible for this increased IL-10 phenotype. Importantly, we
also observed that inhibition of IL-10 from C5.507 Vi
+ stimulated
splenocytes in vitro directly impacted both chemotaxis and
activation status of immune cells. Notably, previous studies have
shown that IL-10 can inhibit chemokine expression and reduce
iNOS production from PMN [21,22]. Therefore, early production
of IL-10 after infection with Vi
+ Salmonella may be important in
diminishing neutrophil influx and activation and thereby increas-
ing the ability of this pathogen to efficiently colonise and infect
distal sites within the host. At later infection time-points Vi may be
an important mechanism associated with dampening the TH-1
response that is normally associated with resolving infections by
invasive bacterial pathogens. Indeed, higher levels of IL-10, as well
as IL-4, have been detected in PBMC culture of typhoid fever
patients when compared to healthy control subjects.
S. Typhimurium C5507 Vi
+ provides a model pathogen to study
the impact of Vi and potentially other S. Typhi specific virulence
genes encoded on SPI-7, in the well characterized murine typhoid
model. Recently, two excellent murine models for typhoid fever
have been described [23,24]. The utility of S. Typhimurium
C5507 Vi
+ as a model system has previously been demonstrated in
studies to determine the protection afforded by a conjugated Vi
subunit vaccine [25]. Furthermore, S. Typhimurium C5507 Vi
+
has been used to studies expression of Vi polysaccharide capsule
from heterologous promoters including PssaG, to improve the anti-
Vi immune response to live oral vaccines against typhoid
(unpublished observations). However, observations from the use
of a surrogate infection models should be considered with care.
Many differences between the chimera infection of mice remain
Figure 7. Vi expression also impacts on the cytokine profile of cells after S. Typhimurium infection. Isolated splenocytes after i.v.
infection (A) or MLN after oral infection (B) from naı ¨ve, or 24 h infected C5507 (Vi
+) and SGB1 (Vi
2) mice were stimulated for 6 h with BD Leukocyte
Activation Cocktail with BD GolgiPlug (BD Biosciences) in vitro, permeabilised and stained with anti-cytokine flurochrome-labelled mAb. (C) Cells were
stained with mAb to specific surface markers F4/80
+, CD11c
+ and DX5
+/CD3
2 the identity of innate populations, permeabilised and stained with anti-
IL-10. Data represent percent of cytokine positive cells out of total spleen populations 6 SEM. Significant differences in values of * p,0.05;
**, p,0.01; ***, p,0.001, as determined by one-way ANOVA followed by Bonferroni’s multiple comparison test.
doi:10.1371/journal.ppat.1002131.g007
Table 2. Total number of cytokine producing cells after
infection with Vi
+ or Vi
2 S. Typhimurium.
tissue cytokine naı ¨ve Vi
+ Vi
2
spleen MIP-2 103.4612.7 190.5619.5 562.2680.3
***{{{
TNF-a 129.1618.1 272.6636.5 625.4657.3
***{{{
IFN-c 122.1617.9 163.3622.7 428.5657.1
***{{{
IL-10 129.9620.6 323.1630.9
*** 246.6630.2
*
perforin 311.3647.4 637.26113.3 1529.06240.5
***{{
IL-6 114.4615.0 165.6616.1 269.5646.7
**
MLN MIP-2 7.560.6 11.661.1 35.864.2
***{{{
TNF-a 18.562.4 44.765.5
** 74.165.5
***{{{
IFN-c 13.761.9 21.263.0 31.262.9
***{
IL-10 11.961.3 32.262.9
*** 30.562.7
***
perforin 24.363.2 51.865.4 106.3612.8
***{{{
IL-6 14.261.4 20.961.4 54.165.4
***{{{
Total cell number for spleen (i.v. infection) or MLN (oral infection) after 24 h
(1610
4) 6 SEM.
*indicates significant values of p,0.05;
**, p,0.01;
***, p,0.001, as determined by one-way ANOVA followed by Bonferroni’s
multiple comparison test when compared to naı ¨ve mice.
{indicates significant values of p,0.05;
{{,p ,0.01;
{{{,p ,0.001, as determined by one-way ANOVA followed by Bonferroni’s
multiple comparison test when Vi
+ are compared to Vi
2 infected mice.
doi:10.1371/journal.ppat.1002131.t002
Table 3. Vi impacts on the cytokine profile of innate cells
shortly after infection.
cell type cytokine naı ¨ve Vi
+ Vi
2
F4/80
+ MW MIP-2 21.261.7 18.461.5 35.761.4
***{{{
TNF-a 25.760.8 29.660.6 37.861.3
***{{
IFN-c 10.260.5 11.960.5 17.261.1
***{{{
IL-6 24.061.0 18.461.5
* 23.761.0
{
CD11c
+ DC MIP-2 8.160.7 7.96 0.8 14.761.0
***{{{
TNF-a 12.861.4 12.260.7 15.561.2
IFN-c 15.260.4 16.360.8 20.660.8
***{{{
IL-6 13.160.7 15.461.2 13.461.0
DX5
+/CD3
2 NK cells MIP-2 14.461.1 8.760.5
*** 18.360.9
**{{{
TNF-a 14.561.2 20.961.6
* 30.061.7
***{{{
IFN-c 18.961.2 18.461.8 27.561.0
***{{{
IL-6 8.961.0 10.260.9 16.861.5
***{
perforin 38.961.6 48.562.1 66.863.7
***{{{
Ly6G
+ PMN MIP-2 8.060.4 6.660.4 11.161.1
*{{{
TNF-a 23.460.9 25.661.3 29.260.9
*
IFN-c 15.260.8 14.660.7 22.161.0
*{
IL-6 19.861.7 18.261.4 20.961.1
Cells were stained with mAb to specific surface markers F4/80
+, CD11c
+, DX5
+/
CD3
2 and Ly6G
+ to identify innate populations, permeabilised and stained with
anti-MIP-2, TNF-a, IFN-c, perforin and IL-6. Data represent percent of cytokine
positive cells out of total spleen populations 6 SEM.
*indicates significant values of p,0.05;
**, p,0.01;
***, p,0.001, as determined by one-way ANOVA followed by Bonferroni’s
multiple comparison test when compared to naı ¨ve mice.
{indicates significant values of p,0.05;
{{,p ,0.01;
{{{,p ,0.001, as determined by one-way ANOVA followed by Bonferroni’s
multiple comparison test when Vi
+ are compared to Vi
2 infected mice.
doi:10.1371/journal.ppat.1002131.t003
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these is that rate at which the infection proceeds and the dynamics
of colonisation and clearance. These differences are likely
accounted for in the genetic differences outside of the chimera
region and also differences in the host species.
Together these data describe the impact of Vi expression on the
outcome and innate immune response to S. Typhimurium infec-
tions in mice. Modulation of the innate immune response by the
Vi polysaccharide capsule decreased innate cell recruitment and
provided insights into how S. Typhi effects its interaction with the
host to provide the desired outcome from the host-pathogen
interaction. This is consistent with a pathogenic strategy central to
which is a slowly progressing systemic disease that is rarely
associated with death from sepsis or cytokine storm, but that
ultimately provides access for this pathogen to the gall bladder and
potentially other immune privileged niches, required for chronic
carriage.
Materials and Methods
Bacterial strains and culture conditions
S. Typhimurium C5507 Vi
+ was a gift from M. Popoff (Institute
Pasteur, France) and was generated by conjugation of S. enterica Typhi
Ty2 with S. enterica Typhimurium C5. A serotype Typhimurium
strain in which the phoN gene was replaced by the aph gene was
constructed by transferring the aph gene from AJB715 into strain
SL1344 by P22 transduction. This derivative was designated
AMJ204. SGB1 Vi2 strain was generated by precise deletion of
the tviB gene and replacement of this with the aph gene that confers
resistance to kanamycin using the Datsenko and Wanner red
recombinase allelic exchange methodology [26]. Oligonucleotide
primers 59 GCCAGAACCAGTTTGGTCCGTAGTTCTTCG-
TAAGCCGTCATGATTGTGTAGGCTGGAGCTGCTTCG 39
and 59 AATTAACTTTGTAAATATAAAATTTTAGTAAAGG-
ATTAATAAGAGCATATGAATATCCTCCTTAG 39 were used
to amplify the aph gene from pKD4 template. Strain SGB1 expressed
comparable amounts of flagellin on culure in LB broth in vitro as
determined by crude flagella preparation and separation of flagellin
monomer by SDS PAGE (data not shown). Bacteria were cultured
aerobically at 37uC in Luria-Bertani (LB) broth or LB with 15% agar
supplemented with antibiotics at appropriate concentrations; ampi-
cillin (Amp), 100 mg/L (LB+Amp); chloramphenicol (Chl), 30 mg/L
(LB+Chl); and kanamycin (Kan), 30 mg/L (LB+Kan).
Sequence analysis
To identify the boundaries of S. Typhi and S. Typhimurium-
derived genomic sequence, genomic DNA was prepared from S.
Typhimurium C5507 and sequenced using the Illumina/Solexa
Genome Analyser. Over 6.5 million single end reads of 36 bp were
generated, giving a theoretical 48-fold coverage of the S.
Typhimurium genome. Reads were mapped to the reference
genomes S. Typhimurium LT2 (EMBL:AE006468) and S. Typhi
CT18 (EMBL:AL513382) using Maq (maq.sourceforge.net), single
nucleotide polymorphisms between C5507 and the reference
genomes were identified. The position and density of these
substitutions compared to the two reference genomes was
visualised using Artemis and ACT (Artemis Comparison Tool)
[27].
Transmission Electron Microscopy (TEM)
Bacteria cultured for 24 hr at 37uc were sampled selecting a
single colony from each strain, mixing with 20 ml sterile distilled
water and rapidly freezing in a Bal-Tec HPM010 high pressure
freezer. Samples for immunogold-labelling were freeze-substituted
in a Leica EM AFS at 290uC in methanol containing 0.2% uranyl
actetate and 0.1% glutaraldehyde followed by low temperature
embedding in Lowicryl HM20 resin. Samples for ultrastructural
analysis were freeze-substituted with acetone containing 0.1%
tannic acid, 0.5% glutaraldehyde sequentially with acetone
containing 1% osmium tetroxide and 0.1% uranyl actetate
followed by room temperature embedding in TAAB 812 resin.
50 mm ultrathin sections were cut on a Leica EM UC6 and
contrasted with lead citrate and uranyl acetate For immunogold-
localisation ultrathin sections were labelled with anti Vi antibody
and probed with protein A gold as previously described [28].
Images were taken on an FEI Tecnai Spirit 120 kV TEM with a
Tietz F415 CCD camera. For quantification of labelling fifteen
random clearly defined bacteria were selected and the number of
associated 10 nm gold particles counted.
Experimental infections of mice
Female wild-type (WT) C57BL/6 and 129/sv mice (6–8 week old)
and knock-out (KO) C57BL/6 mice, including MyD88
2/2 [29] and
TLR4
2/2 [30] were kind gifts and were bred at The Sanger Institute
Research Support Facility (RSF). All animals were given food and
water ad libitum. Mice were sacrificed by cervical dislocation or
Figure 8. Vi modulates innate immune responses through TLR. Spleens were removed from naı ¨ve, WT or KO animals (both MyD88
2/2 and
TLR4
2/2) infected with C5.507 (Vi
+) or SGB1 (Vi
2) 24 h after infection. The cfu per g of tissue (A) and the percentage of splenocytes that were Ly6G
+
(B) or DX5
+/CD3
2 (C) were determined. Columns represent the percentage of cells 6 SEM. Significant differences are indicated * p,0.05; **, p,0.01;
***, p,0.001, and for comparison of Vi
+ compared to Vi
2 infected mice,
{{ p,0.01;
{{{,p ,0.001, as determined by one-way ANOVA followed by
Bonferroni’s multiple comparison test. # Colonisation data for two of the mice in the TLR4
2/2 mouse group inoculated with C5.507 were not
determined.
doi:10.1371/journal.ppat.1002131.g008
Table 4. Total number of PMN and NK cells after infection with Vi
+ or Vi
2 S. Typhimurium in TLR4
2/2 and MyD88
2/2 mice.
cell type naı ¨ve WT Vi
+ TLR4
2/2 Vi
+ MyD88
2/2 Vi
+ WT Vi
2 TLR4
2/2 Vi
2 MyD88
2/2 Vi
2
Ly6G
+ PMN 196.6621.2 597.3678.7
* 399.2673.3 454.1647.0 1580.06130.9
** 909.66105.0
**{{ 501.9664.1
{{
DX5
+/CD3
2 NK 133.2617.2 261.4639.4 193.3613.7
**{{ 267.0641.7 1149.16143.9
** 909.66105.0
**{{ 241.9664.4
{{
Total cell number of PMN and NK cells in the spleen 24 h post (610
4) 6 SEM.
*indicates significant values of *, p,0.01;
**, p,0.001, as determined by one-way ANOVA followed by Bonferroni’s multiple comparison test when compared to naı ¨ve mice.
{indicates significant values of {,p ,0.01;
{{,p ,0.001, as determined by one-way ANOVA followed by Bonferroni’s multiple comparison test when WT Vi
2 are compared to KO Vi
2 infected mice.
doi:10.1371/journal.ppat.1002131.t004
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in LB broth (with appropriate antibiotics) for 20 h. Bacteria were then
harvested by centrifugation, washed, and suspended in PBS (pH 7.4) to
approximately 10
9 CFU per ml. Groups of 5–10 mice were inoculated
orally by gavage or intravenously with 0.2 ml of bacterial suspension.
Viable counts were determined in the inoculum by serial dilutions onto
LB agar. After 24 h or five days the mice were culled and their MLN,
terminal end ileum, cecum, spleen, and liver were aseptically removed
and weighed. Organs were homogenised in sterile water (5 ml) using a
Seward Stomacher 80 (Seward, London UK) for 2 minutes at high
speed. Serial dilutions of each organ were plated onto LB agar.
Colonies were enumerated after overnight incubation at 37uC.
Ethics statement
All animal procedures were performed in accordance with the
United Kingdom Home Office Inspectorate under the Animals
(Scientific Procedures) Act 1986. Ethical approval for these
procedures were granted by the Wellcome Trust Sanger Institutes
Ethical Review Committee.
Flow cytometry and ELISA
Single cell suspensions from the spleens and MLN of individual
mice were prepared to obtain a final concentration of 5610
5 cells/
well in blocking buffer (16PBS/1% BSA/0.05% sodium azide/1%
rat, hamster and mouse serum). 0.05 ml of each mAb dye mix,
0.005 ml of the amine-reactive viability dye ViViD (Invitrogen) to
determine dead cells, with incubation in the dark at 4uC for
30 minutes. The mAb used for flow cytometry were (BD
Biosciences unless stated otherwise); CD11c, clone HL3 with PE-
Cy7 conjugate (BD Biosciences), Ly6G, clone RB6-8C5 with PE
conjugate (BD Biosciences), CD49b, clone DX5 with FITC or PE
conjugate (BD Biosciences), F4/80, clone BM8 with TRI-COLOR
conjugate (Invitrogen), CD3, clone 145-2C11 with APC, CD69,
clone H1.2F3 with PE-Cy7, Alexa Fluor 700, conjugate (BD
Biosciences), CXCL2/MIP-2, clone 40605 with biotin conjugate
(AbD Serotec), IL-10, clone JES5-16E3 with APC conjugate (BD
Biosciences),TNF-a, cloneMP6-XT22 with PE-Cy7conjugate(BD
Biosciences), IL-6, clone MP5-20F3 with PE conjugate (BD
Biosciences), IFN-c, clone XMG1.2 with PE-Cy7 conjugate (BD
Biosciences), perforin, clone eBioOMAK-D with FITC conjugate
(eBioscience), streptavidin, with PE-Texas Red conjugate (BD
Biosciences). Cells were washed twice with blocking buffer and
finally resuspended in 0.2 ml 1% paraformaldehyde. To perform
flow cytometric analyses and measure relative fluorescence
intensities a FACSAria cytometer and BD Diva software (Becton
Dickinson) were used. For each mouse 20,000–200,000 events were
recorded. The percentage of cells labelled with each mAb was
calculated in comparison with cells stained with isotype control
antibody. Background staining was controlled by labelled isotype
controls and fluorescence-minus-one (FMO). The results represent
the percentage of positively stained cells in the total cell population
exceeding the background staining signal. For determination of
intracellular cytokine production by splenocytes, cells were
incubated for 6 h at 37uC with BD Activation Cocktail (BD
Biosciences) containing Phorbol 12-Myristate 13-Acetate (PMA),
plus GolgiPlug or GolgiPlug alone (BD Biosciences). Cells were then
washed with staining buffer and stained at 4uC with surface mAbs.
Cells were then fixed and saponin-permeabilised (Perm/Fix
solution, BD Biosciences) and incubated with cytokine mAb as
listed above or isotypic controls. After 30 min cells were twice
washed in permealisation buffer (BD Biosciences) and then analysed
by flow cytometry as described above. For determination of IL-10
levels from in vitro stimulated splenocyte supernatants the IL-10
Instant ELISA (Bender MedSystems) system was used according to
manufacturer’s instructions.
In vitro Salmonella stimulations
Spleen suspensions were prepared as described above and
2610
5 cells added to a 96-well round bottom plate and were left
for 1 h at 37uC5 %C O 2. Cells were then stimulated with
appropriate 1:1 ratio of Salmonella strains supplemented with
20 mg/mL anti-IL-10 or appropriate isotype control (PeproTech).
In others, cells were supplemented with 100 ng/mL recombinant
(r)-IL-10 (PeproTech). Splenocytes were also stimulated with LPS
(100 ng/mL) or RPMI
+ medium as positive and negative controls
respectively. Cells were then incubated for approximately 24 h
before being centrifuged at 8006g for 5 min. Some supernatant
was removed and stored at 280uC for subsequent cytokine
analysis. Remaining cells from stimulation were then stained for
flow cytometry with surface (DX5
+/CD3
2 or Ly6G
+) and the
activation marker CD69 as described above.
Chemotaxis assay
Migration of Salmonella stimulated splenocytes was analysed in
96-well QCM Chemotaxis Cell Migration Assay (Millipore, UK)
with 5-mm pore polycarbonate filters. Briefly, 2610
5 cells in 0.1 ml
of RPMI
+ were placed into the migration chambers. Supernatant
from stimulated splenocytes were added to the lower chamber.
Migration was performed for 4 h at 37uC with 5% CO2. Cells/
media from the top chamber of the insert was discarded and
remaining cells removed using Cell Detachment Solution (Milli-
pore, UK). Lysis Buffer/Dye Solution (Millipore, UK) were added
to each well and incubated for 15 min. 0.15 ml of this mixture was
then transferred to new 96-well plate and read with a fluorescence
plate reader using 480/520 nm filter set.
Statistical analysis
Experimental results were plotted and analysed for statistical
significance with Prism4 software (GraphPad, San Diego, CA). A
p-value of ,0.05 was used as significant in all cases.
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Figure 9. Vi induction of IL-10 impacts on chemotaxis and activation of splenocytes in vitro. (A) Spleen cells were isolated from naı ¨ve mice
and stimulated for 24 h with 1:1 ratio of Vi
+ or Vi
2 Salmonella strains and supernatants were analysed for levels of IL-10. Mean 6 SEM are presented
from six individual animals. Significance was determined using Mann-Whitney test, *** p,0.001. (B) Splenocytes were also stimulated with the
various S. Typhimurium strains in the presence of anti-IL-10, isotype control antibody or rIL-10. Cells were then stained with surface antibodies and
the percentage and expression/mean fluorescent intensity (MFI) of the activation marker CD69 on NK cells and PMN was analysed by flow cytometry.
Columns represent the percentage of MFI 6 SEM and significant differences were determined as in Figure 6. (C) Chemotactic migration of
splenocytes towards supernatants from Salmonella stimulated cultures (in the presence of anti-IL-10, control antibody or rIL-10). After 4 h incubation,
the level of cell migration was determined by reading the relative fluorescent units (RFU) at 480/520 nm. Data represents mean 6 SEM minus
negative (media alone) controls. Significant differences in values of * p,0.05; **, p,0.01; ***, p,0.001, as determined by Kruskal-Wallis followed by
Dunn’s multiple comparison test or
{ indicating significant values when compared to r-IL-10.
doi:10.1371/journal.ppat.1002131.g009
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